Abnova (Taiwan)TPE:4133 -1.18%75 Days Inventory is 950.69 as of Dec. 2025, which is 21% above its 10-year median of 783.05. GuruFocus rates TPE:4133 with a GF Score™ of 75/100 and a GF Value™ of NT$28.26 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 635 Biotechnology companies, Abnova (Taiwan) ranks worse than 89.29% on this metric.
The historical rank and industry rank for Abnova (Taiwan)'s Days Inventory or its related term are showing as below:
TPE:4133'
s Days Inventory Range Over the Past 10 Years
Min: 625.74 Med: 783.05 Max: 921.9
Current: 858.63
During the past 13 years, Abnova (Taiwan)'s highest Days Inventory was 921.90. The lowest was 625.74. And the median was 783.05.
TPE:4133's Days Inventory is ranked worse than 89.29% of 635
companies
in the Biotechnology industry
Industry Median: 183.23
vs TPE:4133: 858.63
Abnova (Taiwan)'s Days Inventory
increased
from Dec. 2024 (819.52) to Dec. 2025 (950.69).
It might indicate that Abnova (Taiwan)'s sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Abnova (Taiwan)'s Inventory Turnover for the
three
months ended in Dec. 2025 was 0.10.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Abnova (Taiwan)'s Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 5.55.
Abnova (Taiwan) (TPE:4133) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Abnova (Taiwan)'s Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Abnova (Taiwan)'s Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Abnova (Taiwan) Days Inventory Related Terms
Abnova (Taiwan) Days Inventory Historical Data
* Premium members only.
The historical data trend for Abnova (Taiwan)'s Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4133 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Abnova (Taiwan)'s Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abnova (Taiwan) Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Abnova (Taiwan)'s Days Inventory distribution charts can be found below:
* The bar in red indicates where Abnova (Taiwan)'s Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abnova (Taiwan) (TPE:4133) has a Days Inventory of 950.69 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Abnova (Taiwan) and its competitors. This is 21% above median its historical median of 783.05. Over the past decade, Abnova (Taiwan)'s Days Inventory has ranged from 625.74 to 921.90. According to the industry distribution chart, Abnova (Taiwan) ranks #567 out of 635 companies in the Biotechnology industry, placing it in the top 89.3%.
Is Abnova (Taiwan)'s Days Inventory too high?
Abnova (Taiwan)'s current Days Inventory of 950.69 is 21% above median its 10-year median of 783.05. Over the past 10 years, this metric has ranged from a low of 625.74 to a high of 921.90. The Biotechnology industry median Days Inventory is 183.23. Abnova (Taiwan)'s value of 950.69 is 418.9% above this industry median. Based on the distribution chart, Abnova (Taiwan) ranks #567 out of 635 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Abnova (Taiwan) has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abnova (Taiwan)'s Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Abnova (Taiwan) ranks #567 out of 635 companies for Days Inventory. This places Abnova (Taiwan) in the lower half of its industry. The industry median Days Inventory is 183.23. Abnova (Taiwan)'s value of 950.69 is 418.9% above this benchmark. Historically, Abnova (Taiwan)'s own Days Inventory has ranged from 625.74 to 921.90 over the past decade. While the company's 10-year median is 783.05 vs. the industry median of 183.23, Abnova (Taiwan) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abnova (Taiwan)'s current Days Inventory of 950.69 is 418.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Abnova (Taiwan) and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abnova (Taiwan)'s current Days Inventory is 950.69, which is 21% above median its own 10-year median of 783.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abnova (Taiwan) stock overvalued right now?
Based on GuruFocus' analysis, Abnova (Taiwan) (TPE:4133) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$28.26, compared to a current price of NT$20.95 — trading 25.9% below its estimated fair value. The current Days Inventory is 950.69, which is 21% above median its 10-year median of 783.05 and 418.9% above the Biotechnology industry median of 183.23. Abnova (Taiwan)'s overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Abnova (Taiwan) (TPE:4133), the current Days Inventory is 950.69 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abnova (Taiwan) (TPE:4133) Overvalued in 2026?
Based on GuruFocus' analysis, Abnova (Taiwan) stock appears to be undervalued.
The current stock price of NT$20.95 is trading 25.9% below its estimated GF Value™ of NT$28.26.
GuruFocus considers Abnova (Taiwan) to be Modestly Undervalued.
Key valuation signals for TPE:4133:
Days Inventory: 950.69 (21% above median its 10-year median of 783.05)
GF Value™: NT$28.26 vs. price of NT$20.95 (25.9% below fair value)
Industry Position: 418.9% above the Biotechnology median (#567 of 635)
No single metric tells the full story. See the TPE:4133 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abnova (Taiwan) Corp is engaged in developing, manufacturing, and selling monoclonal antibody, polyclonal antibody, proteins, medical inspection instruments and testing reagents, which are mainly antibody reagents, antibody chips or related products provided to and used by academic, research institutions or pharmaceutical factories. Geographically, it operates in America, Europe, Taiwan and Other Countries. It generates maximum revenue from America. Its products include: SARS-CoV/CoV-2, DNA, RNA new, Proteins/peptides, MaxPab, DNAxPab, Polyclonal Ab, Monoclonal Ab and Others. The company's services are: Gene synthesis & cytogenetics, Peptide services, Protein expression, Humanized antibody, Assay development, Conjugation, FFPE tumor tissue DNA, In situ hybridization (ISH) and Others.
75GF Score
Get the complete analysis for TPE:4133
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4133 has been successfully added to your 
